NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Earnings Season Enters Fourth Week: Key Companies to Watch

As the earnings season enters its fourth week, around 45 companies are scheduled to release their financial results for the quarter ending on March 31, 2026, on Monday, 4 May. Among the marquee companies declaring their Q4 results today are Bharat Heavy Electricals (BHEL), Ambuja Cements, Aditya Birla Capital, Jindal Stainless, Ather Energy, Manappuram Finance, Tata Technologies, and Tata Chemicals.

The earnings-driven action will be a critical factor to watch in today's session, with heavyweights such as Ambuja Cements, Bharat Heavy Electricals Limited, and Tata Technologies expected to play a pivotal role in shaping sectoral sentiment. Strong performance from Ambuja could reinforce confidence in the cement and infrastructure theme, particularly around execution and synergy benefits. BHEL's numbers will be closely tracked as a proxy for capital goods and PSU momentum, where expectations remain elevated. Tata Technologies, meanwhile, will be key for sentiment in the ER&D and IT space, especially following recent underperformance.

Market Performance

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

On Thursday, the Indian stock market closed in the red, with the benchmark Nifty 50 slipping below the 24,000 mark. The Sensex declined by 582.86 points, or 0.75%, to end at 76,913.50, while the Nifty 50 fell 180.10 points, or 0.74%, to settle at 23,997.55.

Ambuja Cements Q4 Results Preview

Brokerage firm Motilal Oswal expects Ambuja Cement's consolidated volume to increase by 10% YoY, aided by inorganic growth. Meanwhile, the brokerage firm anticipates EBITDA to fall 5.5% year-on-year (YoY).

Brokerage FirmConsolidated Volume YoY GrowthEBITDA YoY Growth
Motilal Oswal10%-5.5%
Kotak Institutional Equities18%N/A

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Kotak Institutional Equities believes blended volumes to rise 18% YoY and 1.2% quarter-to-quarter (QoQ). The firm estimates blended realizations to increase qoq by 1.1% (-0.3% yoy) led by improvement in non-trade prices. It also estimates costs/ton to decrease by 1.4% qoq (+3.9 yoy) led by operating leverage.

Tata Chemicals Q4 Results Preview

MOFSL expects Tata Chemicals revenue likely to remain flat, with the pricing and demand outlook on Soda Ash will be the key monitorable. It further expects EBITDA margin is likely to expand 220bp on a YoY basis.

Brokerage FirmConsolidated Revenues YoY GrowthEBITDA Margin YoY Growth
MOFSLFlat220bp
Kotak-6.5%N/A

Kotak estimates a 6.5% yoy decline in consolidated revenues for Tata Chemicals amid continued pressure on soda ash realizations. North America revenues are expected to decline, as the company aims to cut volumes in low-realization Southeast Asia. In other regions, realizations and volumes are expected to remain stable qoq.

Investor Takeaway

Monitor earnings releases from key companies for sectoral sentiment and potential market impact.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.